Cited by 206Genetic Neurodegenerative DiseasesHereditary Neurological DisordersParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort

Open access
For the European Huntington Disease Network, Weydt, Patrick, Soyal, Selma M, Landwehrmeyer, G Bernhard, Patsch, Wolfgang·2014·BMC Neurology

Abstract

BACKGROUND: Genetic modifiers are important clues for the identification of therapeutic targets in neurodegenerative diseases. Huntington disease (HD) is one of the most common autosomal dominant inherited neurodegenerative diseases. The clinical symptoms include motor abnormalities, cognitive decline and behavioral disturbances. Symptom onset is typically between 40 and 50 years of age, but can vary by several decades in extreme cases and this is in part determined by modifying genetic factors. The metabolic master regulator PGC-1α, coded by the PPARGC1A gene, coordinates cellular respiration and was shown to play a role in neurodegenerative diseases, including HD. METHODS: Using a candidate gene approach we analyzed a large European cohort (n = 1706) from the REGISTRY study for associations between PPARGC1A genotype and age at onset (AO) in HD. RESULTS: We report that a coding variant (rs3736265) in PPARGC1A is associated with an earlier motor AO in men but not women carrying the HD mutation. CONCLUSIONS: These results further strengthen the evidence for a role of PGC-1α in HD and unexpectedly suggest a gender effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2377-14-1

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

Sorted by citations

Items 101–200 of 206

Metadata

Authors
For the European Huntington Disease Network, Weydt, P., Soyal, S. M., Landwehrmeyer, G. B., & Patsch, W.
Affiliations
  • Universität Ulm (DE)
  • Paracelsus Medical University (AT)
Corresponding author
Weydt, Patrick
Venue
BMC Neurology
Published
2014-01-02
Volume
14
Issue
1
Pages
1-1
ISSN
1471-2377 (ISSN-L)
OpenAlex
W1990817194
Cited by
206
References
36
Citations by year
2026: 1 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 4 · 2021: 50 · 2020: 25 · 2019: 13 · 2018: 24 · 2017: 29 · 2016: 21 · 2015: 5 · 2014: 8
FWCI
9.59
Type
journal article
Language
en
Open access
Locations
  • BMC Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • European Huntington's Disease Network
  • Austrian Science Fund (P 19893)
  • Deutsches Zentrum für Neurodegenerative Erkrankungen
  • Paracelsus Medizinische Privatuniversität
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
Huntington's disease, PGC-1α, single nucleotide polymorphisms, age of onset, genetic modifiers, sex differences, motor symptoms, neurodegeneration, candidate gene association
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Europe, Female, Humans, Huntington Disease, Male, Registries, Transcription Factors, Cohort Studies, Open Reading Frames, Age of Onset, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review